Last 795.30 INR
Change Today -10.80 / -1.34%
Volume 3.5M
SUNP On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 09/15/14 All times are local (Market data is delayed by at least 15 minutes).

sun pharmaceutical indus (SUNP) Snapshot

Open
804.00
Previous Close
806.10
Day High
815.00
Day Low
792.00
52 Week High
09/3/14 - 878.40
52 Week Low
09/18/13 - 535.55
Market Cap
1.6T
Average Volume 10 Days
2.7M
EPS TTM
15.18
Shares Outstanding
2.1B
EX-Date
09/11/14
P/E TM
52.4x
Dividend
1.50
Dividend Yield
0.19%
Current Stock Chart for SUN PHARMACEUTICAL INDUS (SUNP)

Related News

No related news articles were found.

sun pharmaceutical indus (SUNP) Related Businessweek News

View More BusinessWeek News

sun pharmaceutical indus (SUNP) Details

Sun Pharmaceutical Industries Limited, a specialty pharmaceutical company, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, such as psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics, ophthalmology, diabetology, musculo-skeletal and pain, gynecology, and urology, as well as antiasthamatic and antiallergic. It also provides APIs comprising anticancers, peptides, sex hormones, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.

Founded in 1983

sun pharmaceutical indus (SUNP) Top Compensated Officers

Managing Director, Executive Director and Mem...
Total Annual Compensation: 23.1M
Wholetime Director and Member of Shareholders...
Total Annual Compensation: 23.1M
Whole Time Director
Total Annual Compensation: 8.5M
Compensation as of Fiscal Year 2014.

sun pharmaceutical indus (SUNP) Key Developments

Sun Pharmaceutical Plans To Raise Funds

Sun Pharmaceutical Industries Limited (BSE:524715) intends to raise INR 120 billion through qualified institutional placement (QIP) route. The company will seek shareholders' approval at its 27th annual general meeting to be held by the end of September, 2014.

Sun Pharmaceutical Industries Limited Presents at India Investor Forum, Sep-08-2014

Sun Pharmaceutical Industries Limited Presents at India Investor Forum, Sep-08-2014 . Venue: BAML Office, 2 King Edward Street, London, United Kingdom.

Sun Pharmaceutical Industries Ltd Appoints Uday Baldota as the Chief Financial Officer

Sun Pharmaceutical Industries Ltd. announced that the Board of Directors of the company at its meeting held on August 12, 2014, has appointed Mr. Uday Baldota as the Chief Financial Officer of the Company, as per section 203 of the Companies Act, 2013, with immediate effect.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SUNP:IN 795.30 INR -10.80

SUNP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CareFusion Corp $46.27 USD -0.12
Cipla Ltd/India 630.25 INR +17.50
Dr Reddy's Laboratories Ltd 2,983 INR +24.75
Endo International PLC $64.61 USD +0.15
Lupin Ltd 1,416 INR +56.90
View Industry Companies
 

Industry Analysis

SUNP

Industry Average

Valuation SUNP Industry Range
Price/Earnings 28.1x
Price/Sales 9.9x
Price/Book 8.8x
Price/Cash Flow 26.1x
TEV/Sales 9.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUN PHARMACEUTICAL INDUS, please visit www.sunpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.